Archive for June, 2011
« Previous Entries Next Entries »Charity walks are about community – Ottawa Citizen
Wednesday, June 29th, 2011
Charity walks are about communityOttawa CitizenThe Walk for ALS is an important annual event bringing together our clients, caregivers and supporters to raise awareness and funds to support those diagnosed with amyotrophic lateral sclerosis and to invest in research to find a cause, treatment and …and more »
Hollywood Model Could Create New Stars in R&D: Alice Schroeder – Bloomberg
Wednesday, June 29th, 2011Hollywood Model Could Create New Stars in R&D: Alice SchroederBloombergPrizes have reached as high as $1 million for the most difficult tasks, including finding a biomarker for amyotrophic lateral sclerosis, or Lou Gehrig's disease. Money is important, but solvers also crave the creative challenge and the emotional reward …
Local woman fighting for life, MDA – InMaricopa.com
Tuesday, June 28th, 2011InMaricopa.com Local woman fighting for life, MDAInMaricopa.comThe expected lifespan of someone with ALS is two to five years, but with Walsh's family history, it is usually 10 months. “I can tell you none of these tests are pleasant, but they are worth it if it helps the research and if it leads to a cure [...]
B.C. woman asks Supreme Court to be allowed to die with dignity – Global Edmonton
Tuesday, June 28th, 2011B.C. woman asks Supreme Court to be allowed to die with dignityGlobal EdmontonVANCOUVER – A woman suffering from ALS, also known as Lou Gehrig's disease, has filed an application with the BC Supreme Court to be allowed a choice in her death. Gloria Taylor, 63, has asked to be added as a plaintiff in the [...]
California Stem Cell Leaders Keirstead and Airriess Panelists at Advocacy and … – PR Web (press release)
Tuesday, June 28th, 2011California Stem Cell Leaders Keirstead and Airriess Panelists at Advocacy and …PR Web (press release)CSC is a privately held Delaware Corporation with headquarters and research facilities in Irvine, CA. CSC is currently developing stem cell based therapies for spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS, or Lou Gehrig's …and more »
New Generation of Stem Cell Therapies Enter Clinical Development … – SunHerald.com
Tuesday, June 28th, 2011New Generation of Stem Cell Therapies Enter Clinical Development …SunHerald.comIndustry experts have determined that the following health conditions represent the largest opportunities in the stem cell market: acute myocardial infarction; amyotrophic lateral sclerosis; critical limb ischemia; heart failure; ischemic stroke and …and more »
Professor with ALS leaves his mark on university – Billings Gazette
Tuesday, June 28th, 2011Professor with ALS leaves his mark on universityBillings GazetteWhen he informed his wife Teresa, he did so in professorial fashion, with a three-ring binder full of research material on ALS. Teresa resigned her post on the Missoula County Public Schools board two years into her three-year term, citing “personal …and more »
ALS linked to water, researchers find – The Dartmouth
Tuesday, June 28th, 2011ALS linked to water, researchers findThe DartmouthInitial studies from the University of Miami have found high levels of BMAA in brain samples from ALS patients, according to a May 2011 Discover Magazine article profiling Stommel's research and published online on June 21. Stommel said the growing …
Pharma: Don’t Count Elan Out – Seeking Alpha
Monday, June 27th, 2011Pharma: Don't Count Elan OutSeeking AlphaLike Elan, Proteostasis Therapeutic develops disease-modifying drugs for neurodegenerative disorders, including Parkinson's disease, Huntington's disease, multiple sclerosis and amyotrophic lateral sclerosis (ALS), plus dementia-related diseases, …
Zinc Finger-Based Approach Rectifies Clotting Times in Mice with Hemophilia B – Genetic Engineering News
Monday, June 27th, 2011Zinc Finger-Based Approach Rectifies Clotting Times in Mice with Hemophilia BGenetic Engineering NewsIn development initially for treating diabetic nephropathy, the candidate is also being evaluated for the potential treatment of amyotrophic lateral sclerosis (ALS), spinal cord and traumatic brain injury and stroke. Phase II trials in ALS have already …and more »
« Previous Entries Next Entries »